Blog

Featured post

Truveta and Alpine Immune Sciences announce strategic partnership

This strategic partnership will help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being developed for multiple B cell-mediated autoimmune and inflammatory diseases.

Bar graphic with text: Truveta and Alpine Immune Sciences announce strategic partnership